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Abstract
Purpose of review—Giardia is a common intestinal parasite worldwide, and infection can be 
associated with clear and sometimes persistent symptomatology. However, in children in high 
prevalence settings, it is not associated with or is perhaps even protective against acute diarrhea, 
and the association with long-term outcomes has been difficult to discern.
Recent findings—Recent studies have made progress in helping us disentangle this apparent 
paradox. First, prospective, well-characterized cohort studies have added to the data on the 
association between Giardia and diarrhea in these settings and have further characterized 
associations between Giardia infection and nutrition, gut function, and growth. Second, animal 
models have further characterized the host response to Giardia and helped elucidate mechanisms 
by which Giardia could impair child development. Finally, new work has shed light on the 
heterogeneity of human Giardia strains, which may both explain discrepant findings in the 
literature and help guide higher-resolution analyses of this pathogen in the future.
Summary—The true clinical impact of endemic pediatric giardiasis remains unclear, but recent 
prospective studies have confirmed a high prevalence of persistent, subclinical Giardia infections 
and associated growth shortfalls. Integrating how nutritional, microbial, metabolic, and pathogen-
strain variables influence these outcomes could sharpen delineations between pathogenic and 
potentially beneficial attributes of this enigmatic parasite.
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INTRODUCTION: WHENCE THE BLACK BOX?
Giardia lamblia (also known as G. intestinalis/duodenalis) is one of the most common 
intestinal parasitic infections in both children and adults worldwide. Giardiasis has a clear 
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case definition characterized by malabsorptive diarrhea, abdominal bloating/cramping, and 
weight loss [1] that is reproducible, if strain-dependent, in human volunteers [2] and 
resolves with treatment. Infection can lead to intestinal inflammation [3], systemic cellular 
immunity [4], and lingering symptoms, even for several years [5]. Giardia has also been 
implicated as a cause of diarrhea in travelers from non-endemic to endemic countries [6], 
with the greatest risk amongst backpackers in Asia [7]. Children living in limited-resource 
settings, many of whom are undernourished, harbor a particularly large burden of Giardia 
infection.
However, recent assessments of pathogen-specific diarrhea in such settings find no Giardia-
attributable burden of diarrhea in this population [8, 9*]. Indeed, the finding in several 
studies that Giardia infection is associated with a decreased likelihood of acute diarrhea [6, 
10, 11] has fostered speculation that such colonization is not only inconsequential, but even 
protective in these children. Thus, despite its high prevalence in this vulnerable population, 
Giardia, unlike other enteropathogens (e.g., Campylobacter or Cryptosporidium) is 
completely absent from global burden of disease estimates [12]. Here we review recent work 
that addresses this epidemiological conundrum that seemingly categorizes Giardia 
simultaneously as both harmful pathogen and intestinal commensal.
DOES GIARDIA CAUSE ACUTE DIARRHEA IN HIGH-PREVALENCE 
SETTINGS?
The recently-completed Etiology, Risk Factors, and Interactions of Enteric Infections and 
Malnutrition and the Consequences for Child Health and Development Project (MAL-ED) 
allows for the most comprehensive analysis of Giardia infection in these settings to date. 
Over the period of November 2009 to February 2014, Giardia was detected in two-thirds of 
1,741 children completing the study through 2 years of age, with wide variation in median 
time to first detection among the eight study sites [13]. Giardia was detected in 37 to 95% of 
children at each site within the first two years of life and persistent infection was common. 
However, when adjusting for Giardia detection in non-diarrheal stools and the presence of 
co-pathogens, Giardia was not significantly associated with diarrhea, regardless of site or 
child age [9*]. In other work, Giardia was not an independent risk factor for diarrhea in 
children presenting to clinics after travel to sub-Saharan Africa, Latin America, and South 
Asia, even though it was among the most frequently detected pathogens in 10.1% of stools 
[14]. The strikingly high prevalence of non-diarrheal Giardia infections [6, 8, 9*, 15, 16**] 
is such that Giardia detection has frequently been negatively associated with diarrhea [6, 8, 
17, 18]. Several factors could preferentially decrease the sensitivity of Giardia detection 
preferentially in diarrheal stools. First, metronidazole is commonly used as empiric therapy 
for diarrhea in these settings. Thus, diarrhea could be a marker of metronidazole exposure, 
which could reduce Giardia detection in diarrheal stools. Second, detection artifact due to a 
decreased sensitivity of microscopy-based detection in liquid stools might partially explain 
this phenomenon [18]. However, studies using antigen-based diagnostics that are 
presumably more resistant to such a dilutional effect have corroborated these findings [8], 
and quantitative nucleic-acid based diagnostics have also suggested that higher quantities of 
Giardia are associated with even greater reductions in diarrhea risk [17], an inversion of 
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Koch’s molecular postulates and the opposite of what is seen with pathogens that are clearly 
diarrhea associated [17,19,20]. This suggestion of a protective effect of Giardia against 
diarrhea has primarily come from case-control studies, however prospective studies have 
also found evidence of such [10, 11]. These findings are not universal, and Giardia was not 
seen to be protective against diarrhea in a recent birth cohort study in Bangladesh [16**].
If real, what could explain this protective effect? The list of potential explanations is long, 
and data are few. Early Giardia infection may be an environmental marker of exposure to 
multiple enteropathogens. Thus, children with Giardia infection at baseline in longitudinal 
studies may be more likely to have already developed immunity to these pathogens and be 
less likely to have subsequent clinical diarrhea due to enteric infections. Second, Giardia 
may induce a specific micronutrient deficiency (e.g., iron) that is protective against diarrhea 
[21]. Intriguingly, in one prospective study, the protective effect of Giardia infection on 
acute diarrhea was not discerned in children who were randomized to receive micronutrient 
supplementation [11]. Thirdly, Giardia may more broadly modulate immune responses to 
other pathogens [22] or even directly bind enterotoxins [23]. Finally, unidentified 
environmental or host factors such as breastfeeding practices, genetics, or intestinal 
microbiota could differentially influence Giardia manifestations in young children. Further 
work is needed to understand the specificity and potential mechanisms driving this 
intriguing association.
IS GIARDIA INFECTION ASSOCIATED WITH POOR GROWTH?
Child growth, rather than incident diarrhea, might be a more relevant outcome for estimating 
the burden of endemic pediatric giardiasis. Historically, associations between Giardia and 
impairments in child growth have varied by study, population, and site, leaving unanswered 
questions regarding causal relationships between the parasite and child developmental 
sequelae. In MAL-ED, no consistent association was seen between a high burden of Giardia 
infection during the first two years of life and height attainment over that interval [24]. 
However, there was a strong association between persistent Giardia infection within the first 
six months of life and height attainment at 2 years (Rogawski ET, Bartelt LA, Platts-Mills 
JA, unpublished data). Similarly, in a single site birth cohort in Bangladesh where Giardia 
infection was nearly universal, with an average of 3.5 Giardia positive monthly surveillance 
stools per child in the first year of life, an impact on growth attainment at two years of age 
was seen in children with a first Giardia detection in the first six months of life [16**]. Since 
the majority of first Giardia exposures occur after one year of age, other factors such as total 
pathogen burden had a greater overall effect on childhood growth at two years of age [24]. 
These findings could suggest an early, critical window of childhood vulnerability which is 
seldom captured in a focused manner. However, it is also possible that the chronic 
consequences of Giardia persistence into the second year of life were not yet evident at the 
completion of follow-up. Additionally, ongoing exposures to deworming agents with anti-
giardial activity such as mebendazole for soil-transmitted helminths which overlap with 
Giardia prevalence [25, 26] in older children could also interrupt Giardia persistence and 
abrogate the impact of Giardia on growth in older children.
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WHAT IS THE PATHWAY BETWEEN GIARDIA INFECTION AND POOR 
GROWTH?
The current working model of enteropathogen-associated growth shortfalls in children links 
nutrient deficiencies with microbial-driven intestinal inflammation, gut dysfunction, and 
increased intestinal permeability, termed environmental enteropathy (EE)[27, 28**]. Chronic 
Giardia infection has been associated with altered intestinal architecture and chronic 
lymphocytic inflammation in humans and some experimental models [4, 29, 30]. In MAL-
ED, Giardia infection was associated with an increased lactulose:mannitol (L:M) ratio, 
indicative of increased gut permeability, but fecal myeloperoxidase (MPO), a marker of 
neutrophil inflammation, was paradoxically lower in children with Giardia, and Giardia was 
not associated with increased fecal neopterin as a marker of T-cell activation or the acute 
phase reactant α-1-acid glycoprotein (Rogawski ET, Bartelt LA, Platts-Mills JA, 
unpublished data). Thus, while impaired gut function represents a putative pathway for poor 
growth during giardiasis, the mechanisms appear to be independent of both diarrhea and 
inflammation.
Recent laboratory work supports these findings and suggests new lines of investigation for 
understanding the association between Giardia and poor growth. First, both parasite-induced 
and host cellular- or cytokine-mediated alterations in tight junctions could participate in 
increased gut permeability during giardiasis. For example, direct contact between intestinal 
epithelial cell monolayers and some Giardia strains lead to degradation of cytoskeletal villin 
protein as well as the tight-junction protein zonula occludens 1 (ZO-1) [31*]. In an 
experimental model, Giardia degraded epithelial cell tight junction proteins occludin and 
claudin-4 [32*] and increased para-cellular translocation of intestinal bacteria. 
Inflammation, gut hypersensitivity, and evidence of ongoing bacterial translocation, were 
present well after parasite clearance, suggesting that Giardia-induced alterations in epithelial 
barrier may explain chronic intestinal sequelae following Giardia exposures [5, 33]. Finally, 
host immune responses during experimental Giardia infections also contribute to epithelial 
cell dysfunction and are entirely sufficient to cause microvillus alterations in the absence of 
the parasite [34].
Second, the absence of an association between Giardia and markers of inflammation in 
MAL-ED are consistent with the frequent lack of acute inflammation on histopathology 
during Giardia infection, decreased fecal neutrophil chemotactic markers such as IL-8 
during more prolonged Giardia infections [35], and an association between Giardia and 
lower systemic C-reactive protein levels [11]. Indeed, Giardia contains an impressive 
repertoire of immunoevasive products [36*] that are upregulated upon sensing secreted host 
factors even prior to parasite attachment [37] and could have implications for modulating 
host responses to co-pathogens or resident microbiota. For example, cathepsin B-producing 
Giardia strains are capable of cleaving IL-8 and attenuating neutrophil chemotaxis to 
inflammatory stimuli [38, 39]. Interestingly, inhibition of cathepsin B prevents Giardia-
induced epithelial cell villin protein degradation, potentially linking a single virulence factor 
that could lead to divergent gut permeability and inflammation findings [31*]. Translating 
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similar outcomes into children will require further elucidation of Giardia strain differences 
since this effect was restricted to specific laboratory isolates.
Third, both the finding that persistent Giardia infections have the greatest influence on 
childhood growth and the clear association between Giardia and persistent diarrhea [6] 
suggest that a subset of children fail to make an appropriate immune response. While host 
factors associated with clinical recurrent giardiasis have generally focused on secretory IgA, 
recall assays in travelers with giardiasis have identified IL-17A-producing CD4+ T-cells as 
the predominate memory cell phenotype [40*] in those who cleared parasites more rapidly, 
consistent with recent murine models invoking the role of Th17 cells in Giardia clearance 
[41]. The specific relevance of the Th17 axis during Giardia infection has not been 
elucidated, but since IL17 has been shown to enhance intestinal epithelial barrier function 
[42], determining whether children with persistent Giardia infection have impairments in 
IL17-mediated immunity and consequently barrier dysfunction even in the absence of 
increased inflammation may reveal additional mechanisms driving increased intestinal 
permeability in this population.
Finally, while growth is an important outcome for prospective studies of early child 
development, growth shortfalls remain a non-specific outcome for EE. Ongoing work into 
better non-invasive measures of EE may help also help resolve the relationship between 
Giardia and childhood growth via EE [26, 43, 44]. Recently identified regulators of β-
oxidation and energy flux via nicotinamide metabolism may represent novel metabolic 
pathways driving childhood malnutrition [45*]. Children with Giardia infection excrete 
greater amounts of urinary lipid markers of oxidative damage and erythrocyte catalase, 
suggestive of chronic systemic oxidation [46*]. Experimental models are actively pursuing 
how persistent Giardia infection dysregulates gut microbial-host co-metabolic adaptations to 
the nutrient-deprivation condition. Ascertaining whether such changes are due to direct 
effects of Giardia or alternatively whether either microbial interactions or the immune 
modulation associated with Giardia infection influence the metabonome will be important to 
resolve.
GIARDIA BY ANY OTHER NAME…
G. lamblia is conventionally categorized into eight genotypically distinct assemblages, each 
with a restricted host range, with the majority of human Giardia infections due to 
assemblage A or B. Unlike the characteristics that distinguish the pathogenicity of some 
other enteric infections, no single marker ascribes virulence potential to clinical Giardia 
isolates. Despite clear differences in experimental models and in human volunteers, there 
remains no consistent delineation between assemblage infection type and symptoms [47]. 
An assemblage A human isolate strain (Human Giardia Invader, HGINV) was recently 
identified with mucosal invasive potential, but weight loss in an animal model was no 
greater than infection with a non-invasive and generally less virulent laboratory-passaged 
assemblage A strain [48*].
The two Giardia assemblages are genetically and phenotypically distinguishable [49], 
sharing less than 70% sequence identity across syntenic regions [50]. Within assemblage B 
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there is a consistently greater degree of genetic diversity than assemblage A [51, 52]. 
Additionally, there is ongoing population expansion of Giardia haplotype diversity across all 
continents [53]. Even within a single isolate, Giardia displays a high degree of allelic 
sequence heterozygosity [54]. Proteomics studies reveal that even within the less genetically 
heterogeneous assemblage A, specific differences in proteins correspond with variable gene 
families. Notably, differences in variant surface proteins among eight separate isolates 
aligned with two different profiles that were independent of host origin, sub-assemblage 
designation, or geographic region [55–57]. With an increasing reference database of 
different Giardia laboratory strains, use of optimized techniques to perform whole genome 
sequencing from clinical isolates may help identify strain-specific correlates of disease [58*, 
59]. Applied to field studies, this additional resolution may help separate out the pathogenic 
signal from commensal noise.
CONCLUSION
In conclusion, Giardia has distinct population-dependent epidemiological patterns. The 
parasite can cause malabsorptive diarrhea as well as chronic intestinal sequelae when 
exposures are infrequent and occur later in life, but is at once seemingly inconsequential or 
even beneficial for diarrhea incidence while contributing to impaired intestinal permeability 
and growth attainment when infection occurs in early childhood and where exposures are 
frequent. To consider Giardia a commensal would therefore be inappropriate, however, a 
paucity of clearly defined factors to distinguish virulence strains limits our ability to 
confidently ascribe pathogenicity. In the meantime, the direct influence of host-immune, 
nutritional, and microbial factors on experimental giardiasis outcomes may better classify 
Giardia as a eukaryotic pathobiont in high-prevalence settings with varied pathogenic 
potential across unique isolates and which commonly exists symbiotically but behaves 
opportunistically when genetic and environmental perturbations allow. As such, defining and 
addressing the elusive burden of one of the most common intestinal parasitic infections in 
humans may require broad thinking about complex microbial-host interactions, and careful 
examination and characterization of long-term sequelae.
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• New field studies have helped characterize associations between Giardia and 
both diarrhea and growth in children living in high prevalence settings.
• Recent work in Giardia pathogenesis is helping reconcile possible 
mechanisms through which Giardia could protect against acute diarrhea, but 
simultaneously impair growth attainment in these children.
• Advances in comparative genomics may identify novel characteristics that 
better identify pathogenic Giardia strains, which in turn could help refine 
burden of disease estimates for this complex organism.
Bartelt and Platts-Mills Page 11
Curr Opin Infect Dis. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
